transform="translate(188.000000, 15.000000)"

P.D. Soros Fellowship for New Americans

Share 0

Pavan Cheruvu, 2004

CEO, Axovant Sciences

Pavan Cheruvu is the child of immigrants from India

Fellowship awarded to support work towards an MD in Medicine at Harvard University

PAVAN CHERUVU, M.D., was born in the US to parents who had emigrated from South India and are naturalized US citizens.

Pavan completed his BSE in biomedical engineering and electrical engineering at Duke University, followed by an MS degree in computer science at Oxford University, where he was a Rhodes Scholar. Pavan attained his MD in 2009 at Harvard Medical School and the HST program at MIT. He then went on to complete his internship and residency at Johns Hopkins Hospital and clinical fellowship in cardiology at the University of California, San Francisco.

Pavane has worked with multiple healthcare-focused startup companies in Boston and the San Francisco Bay Area.  He was previously a junior engagement manager at McKinsey & Company. 

Pavan is marrried to Deepu Madduri and they live in New York City with their daughter Sofia.

  • MD Medicine | Harvard University 2009
  • Not Found Health Sciences and Technology | Massachusetts Institute of Technology (MIT) 2009
  • MSc Neuroscience | Oxford University 2004
  • MSc Computer Science | Oxford University 2003
  • BS Biomedical Engineering | Duke University 2002
Work History
  • Axovant Sciences, CEO | February 2018 - PRESENT
  • Roivant Sceinces, Chief People Officer | September 2017
  • Roivant Sciences, Chief of Staff | October 2015
Related Articles

Pavan Cheruvu Named CEO Of Axovant Sciences

2004 Paul & Daisy Soros Fellow Pavan Cheruvu has been named the CEO of Axovant Sciences, a clinical stage biopharmaceutical company. Pavan, who is the child of immigrants from India and a graduate of Harvard Medical School, was previously the chief...

Read More

The New American 2017-2018: Our Alumni Magazine

Read More
Rebecca Beyer

Pursuing the Potential of Abandoned Pharmaceuticals

Two Paul & Daisy Soros Fellows are behind the largest biotech IPO in history—Vivek Ramaswamy (2011 Fellow), the founder and CEO of Roivant Sciences, and Pavan Cheruvu (2004 Fellow), the chief of staff at Roivant Sciences.

Read More